T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Charles Schwab
SCHW
|
+$2.18B |
| 2 |
Airbnb
ABNB
|
+$1.59B |
| 3 |
Goldman Sachs
GS
|
+$1.35B |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$1.27B |
| 5 |
Caterpillar
CAT
|
+$1.24B |
Top Sells
| 1 |
Apple
AAPL
|
+$2.44B |
| 2 |
Qualcomm
QCOM
|
+$1.64B |
| 3 |
Becton Dickinson
BDX
|
+$1.61B |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.43B |
| 5 |
Fidelity National Information Services
FIS
|
+$1.04B |
Sector Composition
| 1 | Technology | 25.04% |
| 2 | Healthcare | 16.2% |
| 3 | Consumer Discretionary | 15.91% |
| 4 | Financials | 12.32% |
| 5 | Communication Services | 11.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Genpact
G
$7.41B
| $11.3M | ﹤0.01% |
273,710
+8
| +0% | +$331 |
|
|
AUY
1327
DELISTED
Yamana Gold, Inc.
AUY
| $11.3M | ﹤0.01% |
1,975,254
+37,668
| +2% | +$215K |
|
1328
SEACOR Marine Holdings
SMHI
$180M
| $11.2M | ﹤0.01% |
4,143,035
-7,832
| -0.2% | -$21.2K |
|
1329
Globant
GLOB
$2.47B
| $11.2M | ﹤0.01% |
51,538
-397
| -0.8% | -$86.4K |
|
1330
BlackLine
BL
$3.36B
| $11.1M | ﹤0.01% |
83,566
+73,513
| +731% | +$9.81M |
|
1331
Dynatrace
DT
$14.8B
| $11M | ﹤0.01% |
253,425
+5,544
| +2% | +$240K |
|
1332
Orchestra BioMed
OBIO
$139M
| $10.9M | ﹤0.01% |
850,000
| – | – |
|
1333
DXC Technology
DXC
$2.51B
| $10.9M | ﹤0.01% |
422,207
-34,266
| -8% | -$882K |
|
1334
Zillow
Z
$21.3B
| $10.7M | ﹤0.01% |
82,425
+7,435
| +10% | +$965K |
|
|
BEAT
1335
DELISTED
BioTelemetry, Inc.
BEAT
| $10.7M | ﹤0.01% |
148,439
-423,015
| -74% | -$30.5M |
|
1336
Protara Therapeutics
TARA
$121M
| $10.5M | ﹤0.01% |
433,598
-14,495
| -3% | -$351K |
|
1337
Leggett & Platt
LEG
$1.3B
| $10.5M | ﹤0.01% |
236,120
-15,178
| -6% | -$672K |
|
1338
Vornado Realty Trust
VNO
$8.25B
| $10.4M | ﹤0.01% |
277,394
-21,842
| -7% | -$816K |
|
1339
Plains GP Holdings
PAGP
$3.7B
| $10.4M | ﹤0.01% |
1,225,178
-1,277,188
| -51% | -$10.8M |
|
1340
Aramark
ARMK
$10.1B
| $10.3M | ﹤0.01% |
371,618
-52,581
| -12% | -$1.46M |
|
1341
Dyne Therapeutics
DYN
$1.87B
| $10.2M | ﹤0.01% |
484,952
-6,519
| -1% | -$137K |
|
1342
Urban Edge Properties
UE
$2.66B
| $10.2M | ﹤0.01% |
785,309
-1,241,551
| -61% | -$16.1M |
|
1343
Fidelity National Financial
FNF
$16.4B
| $10.1M | ﹤0.01% |
267,887
-778
| -0.3% | -$29.2K |
|
1344
First American
FAF
$6.87B
| $10.1M | ﹤0.01% |
194,769
-576,178
| -75% | -$29.7M |
|
1345
Aspen Aerogels
ASPN
$543M
| $9.9M | ﹤0.01% |
593,309
+12,743
| +2% | +$213K |
|
1346
Plug Power
PLUG
$1.76B
| $9.81M | ﹤0.01% |
289,219
+95,324
| +49% | +$3.23M |
|
1347
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.06B
| $9.78M | ﹤0.01% |
304,600
| – | – |
|
1348
Cardiff Oncology
CRDF
$136M
| $9.53M | ﹤0.01% |
529,627
-23,732
| -4% | -$427K |
|
1349
Invitation Homes
INVH
$18.5B
| $9.49M | ﹤0.01% |
319,422
-192
| -0.1% | -$5.7K |
|
1350
Nektar Therapeutics
NKTR
$926M
| $9.33M | ﹤0.01% |
36,593
-37,958
| -51% | -$9.68M |
|